Professor Jo Neill and Parminder Singh bring psychopharmacology and IP protection & licensing expertise to a company pursuing psilocybin-based therapies VANCOUVER, BC, May 25, 2021 /CNW/ – Albert Labs, an innovative developer of psychedelics-based therapeutics addressing urgent and unmet mental health indications through Real World Evidence (RWE) studies in the UK and across Europe…

Source

Previous articleSilo Pharma Submits Application for NASDAQ up-listing
Next articleVirtual Reality and Psychedelic Synergy